SARS CoV-2 vectored vaccine

AIIMS Delhi to start booster dose trial of intranasal Covid vaccine from Friday

Health March 10, 2022

India is yet to approve the use of intranasal vaccine against COVID-19, BBV154 developed by the Hyderabad based company. The…